⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27745365 | 0.97 | — | — | |
| SCHEMBL28352421 | 0.97 | — | — | |
| SCHEMBL1816755 | 0.81 | — | — | |
| SCHEMBL695096 | 0.80 | — | — | |
| SCHEMBL28176525 | 0.77 | TSHR (0.39) | — | |
| SCHEMBL1813417 | 0.75 | — | — | |
| Cyclopropane Carboxylic Acid SCHEMBL28307616 | 0.73 | LMNA (0.46) | — | |
| SCHEMBL2489106 | 0.72 | CYP2C19 (0.33) | — | |
| SCHEMBL2492164 | 0.72 | CYP2C19 (0.33) | — | |
| SCHEMBL1818943 | 0.71 | APLNR (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104334170-B | Use of NEU1 sialidase inhibitors in cancer therapy | 迈伦·R·谢夫丘克 | 2020-02-07 | — | — | CN | claimed |
| CN-1149296-A | Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PROD (US) | 1997-05-07 | — | — | CN | claimed |
| EP-0426253-A1 | Process for the separation of R and S-2,2R1, R2-1,3-dioxolane-4-carboxylic acid | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-05-08 | — | — | EP | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | disclosed |
| CN-115557933-A | Bruton tyrosine kinase and mutant degradation agent, composition and application thereof | 杭州和正医药有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-113891879-A | 3, 6-disubstituted-2-pyridine aldoxime skeletons | 国家科学研究中心 | 2022-01-04 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| US-10800806-B2 | Sterol derivatives and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies | BETA INNOV (FR) | 2020-10-13 | — | — | US | disclosed |
| CN-104334170-B | Use of NEU1 sialidase inhibitors in cancer therapy | 迈伦·R·谢夫丘克 | 2020-02-07 | — | — | CN | disclosed |
| CN-109641866-A | The manufacturing method of monoglyceride | 花王株式会社 | 2019-04-16 | — | — | CN | disclosed |
| CN-109641865-A | Process for producing glycerate | 花王株式会社 | 2019-04-16 | — | — | CN | disclosed |
| WO-2004028445-A2 | PROCESSES FOR PREPARING 1,3-DIOXOLANE NUCLEOSIDES | PHARMASSET INC. (US) | 2004-04-08 | — | — | WO | disclosed |
| CN-1414951-A | Drug discharge pump inhibitor | FUNDAMENTAL THERAPEUTICAL INC (US) | 2003-04-30 | — | — | CN | disclosed |
| CN-1400975-A | Purine derivatives | PFIZER LTD (US) | 2003-03-05 | — | — | CN | disclosed |
| CN-1378551-A | Purine derivatives | PFIZER LTD (US) | 2002-11-06 | — | — | CN | disclosed |
| CN-1059905-C | Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PROD (US) | 2000-12-27 | — | — | CN | disclosed |
| CN-1149296-A | Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PROD (US) | 1997-05-07 | — | — | CN | disclosed |
| EP-0426253-A1 | Process for the separation of R and S-2,2R1, R2-1,3-dioxolane-4-carboxylic acid | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-05-08 | — | — | EP | disclosed |
| EP-0426253-A1 | Process for the separation of R and S-2,2R1, R2-1,3-dioxolane-4-carboxylic acid | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-05-08 | — | — | EP | disclosed |
| EP-0405691-A1 | A process for the preparation of a S-2,2-R1,R2-1,3-dioxolane-4-methanol | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-01-02 | — | — | EP | disclosed |